Desq Long
Sign in

Company

Crinetics Pharmaceuticals, Inc.

CRNX · CIK 0001658247

SEC FORM 4
$0.00

Crinetics Pharmaceuticals, Inc. (CRNX)

Acquisition (code A) of 471 shares at $0 per share.

Reporting Person Schilke Tobin · Officer Title Chief Financial & Infra. Ofcr. · Transaction Code A

Traded Aug 20, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001628280-26-058664 · filed 2026-08-24 · View filing →